Faruqi & Faruqi, LLP is reminding Boston Scientific (BSX) investors of the May 4, 2026, deadline to seek lead plaintiff status in a federal securities class action lawsuit. The lawsuit alleges that Boston Scientific made misleading statements regarding its U.S. EP segment's growth rate and competitive landscape, surprising investors with a net income miss and underwhelming guidance for fiscal 2026. The firm encourages investors who suffered losses between July 23, 2025, and February 3, 2026, to contact them to discuss their legal options.

Capital One Financial (COF) receives a hold rating due to anticipated integration costs from its Discover and Brex acquisitions, which are expected to depress earnings over the next 12-24 months. While the transformation into a closed-loop payments network is strategically significant, the company faces macroeconomic headwinds such as rising consumer delinquencies and higher-for-longer interest rates. With its valuation trading near peer medians, immediate upside potential is limited despite operational improvements.

Faruqi & Faruqi, LLP has reminded investors of Gartner (IT) about the May 18, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The lawsuit alleges that Gartner made false and/or misleading statements regarding its growth rates and ability to meet financial targets, causing investors to purchase securities at inflated prices. The complaint details a significant stock price drop following Gartner's Q4 2025 financial results and 2026 outlook which missed analyst expectations.

Faruqi & Faruqi, LLP is reminding investors of the May 15, 2026, deadline to seek lead plaintiff status in a securities class action lawsuit against Grocery Outlet Holding Corp. The lawsuit alleges that Grocery Outlet made false and misleading statements about its growth strategy, which was supported by excessive store expansion that led to inability to meet guidance, store closures, and asset write-downs. Investors who purchased securities between August 5, 2025, and March 4, 2026, and suffered losses are encouraged to contact the firm.

Biogen Inc. is at a pivotal moment, with its neurology-focused pipeline, especially in Alzheimer's and MS treatments, potentially driving renewed growth despite patent cliffs. The company's U.S.-centric business model and R&D investments aim to address significant unmet medical needs. While analysts generally hold a positive outlook due to robust demand and pipeline catalysts, risks like patent expirations and competition could impact its future.

GSK is making a significant investment in its B7-H4 antibody-drug conjugate (ADC) program, with plans to initiate five Phase III trials. This move highlights GSK's commitment to strengthening its ADC portfolio, following previous related announcements regarding B7-H3 ADCs and a pact with Oxford BioTherapeutics. The company is actively pursuing new launches and R&D acceleration to counter sales headwinds.

The article reports on the top ten large-cap stock losers from April 6-10, with Cloudflare, ServiceNow, and Guardant Health being notable mentions. Weak macro signals, rising AI competition, and analyst downgrades contributed to a broad sell-off across software and cloud companies. Despite some companies making product launches or strategic moves, their stock prices experienced significant weekly declines.

UnitedHealth Group (UNH) saw its stock price increase by 9.76% in the past week following an announcement from the Centers for Medicare & Medicaid Services regarding a 2.48% increase in Medicare Advantage reimbursement rates for 2027, exceeding initial expectations. The company, a major healthcare insurer with a $276.23 billion market cap and a GF Score of 72/100, is benefiting from this positive development. Insider activity also shows confidence, with 5 insider buys against 2 sells in the last 12 months.

Hedeker Wealth LLC, an institutional investor, has decreased its stake in Citigroup Inc. by 19.6% in the fourth quarter, according to a recent SEC filing. The firm now holds 73,956 shares of Citigroup stock, representing an $8.63 million valuation and making it the 18th largest holding in Hedeker Wealth's portfolio. This reduction reflects broader trends in the financial sector, as investors respond to evolving economic conditions and regulatory changes impacting major banks.

This article provides information on the net current asset value per share for Public Storage, traded under the symbol PUP on GETTEX. The content is primarily a data page from TradingView, displaying financial metrics but without specific numerical data in the provided snippet. It also lists various data providers and copyright information.